NewsRx

Search our medical news database

Patents

CytoGenix files U.S. patent application for cancer treatment

Published in Cancer Weekly, September 19th, 2006

CytoGenix, Inc. (CYGX) announced that it has filed a patent application entitled "Single Stranded Expression Systems for Cancer Genetics and Other Applications" with the U.S. Patent and Trademark Office.

The patent application is based on the results of recent experiments published in the journal Clinical Cancer Research by the inventors, CytoGenix' chief scientific officer, Dr. Yin Chen, and CytoGenix director and scientific advisor, Dr. Cy A. Stein, professor of medicine at Albert Einstein College of Medicine and Montefiore Medical Center. These experiments show that the company's proprietary ssDNA technology effectively combats some types of tumor growth and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook